Biolyst LLC is seeking $1.25 million from the sale of equity and options, according to a Securities & Exchange Commission filing.
The Plymouth, Minn.-based company wants to franchise a laser system that treats peripheral neuropathy, a painful nerve disease. Biolyst, which plans to launch the system this quarter, is targeting 30 chiropractor and podiatry clinics a year, or about 200 clinics in five years, CEO Phil Walter said in a telephone interview.